Side Effects & Safety11 min readUpdated 2026-04-08

    Noom Med Side Effects 2026: GLP-1 Side Effects & What to Expect

    Comprehensive guide to Noom Med GLP-1 side effects in 2026. Learn about common and rare side effects, how Noom manages them, and how Trimi's $99/mo semaglutide compares.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. Our team reviews side effect profiles to help patients make informed treatment decisions.

    Quick links: Semaglutide treatment, cheapest GLP-1 injections 2026, and Henry Meds side effects.

    Understanding Noom Med Side Effects

    Noom Med is the prescription medication arm of Noom's weight loss platform, offering GLP-1 medications like semaglutide and tirzepatide alongside their well-known behavioral coaching program. At $149 to $209 per month, Noom Med combines medication with their psychology-based approach to weight management.

    An important truth about GLP-1 side effects: they are caused by the medication, not the platform prescribing it. Whether you get semaglutide from Noom Med, Trimi, or any other provider, the side effect profile is identical because the active ingredient is the same. What differs between providers is how side effects are managed — dose titration protocols, provider responsiveness, and supportive guidance.

    This guide covers the side effects you can expect from Noom Med's GLP-1 medications, how they compare to other providers, and what strategies are most effective for managing them.

    Common GLP-1 Side Effects on Noom Med

    The following side effects are reported across all GLP-1 providers including Noom Med. Incidence rates are based on clinical trial data for the active ingredients.

    Side EffectSemaglutide IncidenceTirzepatide IncidenceTypical Duration
    Nausea30 - 45%25 - 35%2 - 8 weeks
    Diarrhea15 - 30%15 - 25%1 - 4 weeks
    Constipation15 - 25%10 - 20%Ongoing for some
    Vomiting10 - 15%5 - 15%1 - 4 weeks
    Abdominal Pain10 - 20%5 - 15%1 - 4 weeks
    Headache10 - 15%5 - 10%1 - 2 weeks
    Fatigue5 - 10%5 - 10%2 - 4 weeks
    Injection Site Reaction5 - 10%5 - 10%Minutes to hours

    These rates are identical across all providers including Noom Med, Trimi, Hims, Ro, and others — because the medication itself causes the effects, not the platform. The incidence rates above reflect clinical trial data from the STEP and SURMOUNT trials.

    Serious Side Effects to Watch For

    While most GLP-1 side effects are mild and temporary, there are rare but serious side effects that require immediate medical attention. These apply to all GLP-1 medications regardless of provider.

    Pancreatitis: Severe, persistent abdominal pain that may radiate to the back — seek emergency care immediately

    Gallbladder problems: Right upper abdominal pain, nausea, and fever may indicate gallstones — contact your provider

    Severe allergic reactions: Difficulty breathing, swelling of face or throat, severe rash — seek emergency care

    Kidney problems: Decreased urination, swelling in legs, persistent nausea — may indicate dehydration-related kidney stress

    Thyroid tumors: GLP-1 medications carry a boxed warning about thyroid C-cell tumors based on animal studies — report any neck swelling or difficulty swallowing

    How Noom Med Manages Side Effects

    Noom Med's approach to side effect management combines their behavioral coaching program with standard medical protocols. Here is how they handle it compared to other providers.

    Management StrategyNoom MedTrimi
    Dose TitrationGradual (standard)Gradual (standard)
    Provider CommunicationMessaging within appMessaging + video
    Response Time24 - 48 hours typical24 hours typical
    Dietary GuidanceCoaching-integratedProvider guidance
    Dose AdjustmentProvider-initiatedProvider-initiated
    Cost During Side Effects$149 - $209/mo$99/mo
    Pause OptionAvailableAvailable (no contract)

    Strategies to Minimize Side Effects

    These evidence-based strategies apply regardless of whether you use Noom Med, Trimi, or any other GLP-1 provider.

    Follow the dose titration schedule: Starting low and increasing gradually is the single most effective way to reduce nausea

    Eat smaller, more frequent meals: Large meals overwhelm the slowed gastric emptying caused by GLP-1 medications

    Avoid high-fat and greasy foods: These are the most common triggers for GLP-1-related nausea and diarrhea

    Stay well hydrated: Dehydration from vomiting or diarrhea can worsen side effects and stress the kidneys

    Eat slowly and stop when satisfied: GLP-1 medications reduce appetite — eating past satiety increases nausea risk

    Take injectable doses at consistent times: Maintaining a regular schedule helps your body adjust predictably

    Noom Med vs Trimi: Cost During Side Effect Management

    One underappreciated factor in side effect management is cost. When patients experience side effects that require dose adjustments, slower titration, or temporary pauses, they are still paying their monthly subscription. Lower monthly costs mean less financial pressure during the adjustment period.

    ScenarioNoom Med CostTrimi CostSavings
    3-Month Adjustment Period$447 - $627$297$150 - $330
    6-Month Treatment$894 - $1,254$594$300 - $660
    12-Month Treatment$1,788 - $2,508$1,188$600 - $1,320

    Bottom Line

    Noom Med's GLP-1 side effects are identical to every other provider's because the medication itself causes the effects. What matters is how side effects are managed and how much you pay during the adjustment period. Trimi offers the same compounded semaglutide at $99 per month with responsive provider support — saving $600 to $1,320 over 12 months compared to Noom Med while providing equivalent side effect management.

    Frequently Asked Questions

    What are the most common Noom Med side effects?

    The most common side effects reported by Noom Med patients using GLP-1 medications include nausea (affecting 30 to 45 percent of patients initially), diarrhea, constipation, vomiting, and injection site reactions. These are consistent with GLP-1 medication side effects regardless of the provider, as the medication itself causes the effects — not the platform.

    Are Noom Med side effects different from other GLP-1 providers?

    No. Since GLP-1 medications like semaglutide and tirzepatide cause the same side effects regardless of where you get them, Noom Med patients experience the same side effect profile as patients on any other platform. The difference is in how the provider manages side effects — dose titration speed, provider responsiveness, and supportive guidance.

    How does Noom Med manage GLP-1 side effects?

    Noom Med manages side effects through gradual dose titration, provider consultations, and their behavioral coaching program which may include dietary guidance to minimize gastrointestinal symptoms. However, these management strategies are standard across most telehealth GLP-1 providers including Trimi.

    Do Noom Med side effects go away?

    For most patients, the most common GLP-1 side effects like nausea diminish significantly within 4 to 8 weeks as the body adjusts to the medication. Gradual dose titration — starting at a lower dose and increasing slowly — is the most effective strategy for minimizing side effects, and this is standard practice across all providers.

    Is Noom Med safe for long-term use?

    GLP-1 medications like semaglutide have been studied in clinical trials lasting up to 68 weeks with favorable safety profiles. Long-term safety is established by the medication itself, not the prescribing platform. Noom Med, Trimi, and other providers all prescribe the same active ingredients with the same long-term safety data.

    Can I reduce Noom Med side effects?

    Yes. Common strategies include eating smaller meals, avoiding high-fat or greasy foods, staying hydrated, eating slowly, and following the dose titration schedule your provider recommends. These strategies work regardless of your provider. If side effects are severe, your provider can adjust your dose or recommend supportive treatments.

    Should I switch from Noom Med due to side effects?

    Side effects are caused by the medication, not the provider. Switching platforms will not eliminate side effects. However, if Noom Med's provider support for managing side effects is inadequate, or if cost is a concern at $149 to $209 per month, switching to Trimi at $99 per month provides the same medication with responsive provider support at a lower price.

    Sources & References

    1. Noom Med prescription weight loss program.
    2. STEP 1 trial: semaglutide side effect profile (PubMed).
    3. SURMOUNT-1 trial: tirzepatide safety data (PubMed).
    4. FDA guidance on compounding.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Side effects can vary by individual. Trimi is a competitor to Noom Med — readers should be aware of our perspective.

    What should patients know about GLP-1 side effects?

    Peer-reviewed / regulatory evidence: In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. (Source: STEP 1, NEJM 2021). Trimi's clinical-review process — coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network — addresses GLP-1 side effects as part of the individualized patient-care plan. Compounded medications are dispensed by 503A community sterile compounding pharmacies (VialsRx, GreenwichRx). This is general information based on the cited sources, not medical advice.

    In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. — STEP 1, NEJM 2021
    In SURMOUNT-1, gastrointestinal adverse events occurred in approximately 81% of tirzepatide 15 mg participants vs 53% of placebo participants over 72 weeks; most resolved with continued therapy and dose adjustment. — SURMOUNT-1, NEJM 2022

    Key Takeaways

    • In STEP 1, the most-reported adverse events with semaglutide 2.4 mg vs placebo were nausea (approximately 44% vs 16%), diarrhea (approximately 32% vs 11%), vomiting (approximately 25% vs 6%), and constipation (approximately 24% vs 11%). Most events were mild-to-moderate and most common during dose escalation. (Source: STEP 1, NEJM 2021)
    • In SURMOUNT-1, gastrointestinal adverse events occurred in approximately 81% of tirzepatide 15 mg participants vs 53% of placebo participants over 72 weeks; most resolved with continued therapy and dose adjustment. (Source: SURMOUNT-1, NEJM 2022)
    • Most GLP-1 adverse events are gastrointestinal (nausea, vomiting, diarrhea, constipation), mild-to-moderate in severity, and concentrated during dose-escalation weeks. Severe or persistent symptoms should be discussed with the prescribing clinician promptly.
    • GLP-1 receptor agonists require a prescription. Eligibility is determined by a licensed clinician based on BMI, weight-related comorbidities, and screening for contraindications (medullary thyroid carcinoma history, MEN 2, pancreatitis history, severe GI / renal disease, pregnancy, breastfeeding).
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 8, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) Prescribing Information — Adverse Reactions section. FDA.Read Study
    2. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information — Adverse Reactions section. FDA.Read Study
    3. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — Safety endpoints. New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183

    Was this article helpful?

    Keep Reading

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Side Effects & Safety

    Compounded Semaglutide Safety

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Side Effects & Safety

    Semaglutide Side Effects

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Clinician-reviewed guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares.

    Start your GLP-1 journey — from $99/mo

    Get Started